PMC:7443692 / 3657-4024
Annnotations
LitCovid-sample-MedDRA
{"project":"LitCovid-sample-MedDRA","denotations":[{"id":"T3","span":{"begin":142,"end":165},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"}],"attributes":[{"id":"A3","pred":"meddra_id","subj":"T3","obj":"http://purl.bioontology.org/ontology/MEDDRA/10058063"}],"text":"nd entry into host cells along with their location on the viral surface, Spike proteins are often used as immunogens for vaccines to generate neutralizing antibodies and frequently targeted for inhibition by small molecules that might block host receptor binding and/or membrane fusion (Li, 2016; Watanabe et al., 2019). In similar fashion, wild-type or catalytically"}
LitCovid-sample-CHEBI
{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T18","span":{"begin":79,"end":87},"obj":"Chemical"}],"attributes":[{"id":"A18","pred":"chebi_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"nd entry into host cells along with their location on the viral surface, Spike proteins are often used as immunogens for vaccines to generate neutralizing antibodies and frequently targeted for inhibition by small molecules that might block host receptor binding and/or membrane fusion (Li, 2016; Watanabe et al., 2019). In similar fashion, wild-type or catalytically"}
LitCovid-sample-UniProt
{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T402","span":{"begin":73,"end":87},"obj":"Protein"}],"attributes":[{"id":"A402","pred":"uniprot_id","subj":"T402","obj":"https://www.uniprot.org/uniprot/P31340"}],"text":"nd entry into host cells along with their location on the viral surface, Spike proteins are often used as immunogens for vaccines to generate neutralizing antibodies and frequently targeted for inhibition by small molecules that might block host receptor binding and/or membrane fusion (Li, 2016; Watanabe et al., 2019). In similar fashion, wild-type or catalytically"}
LitCovid-sample-PD-IDO
{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T22","span":{"begin":3,"end":18},"obj":"http://purl.obolibrary.org/obo/GO_0044409"},{"id":"T23","span":{"begin":14,"end":18},"obj":"http://purl.obolibrary.org/obo/IDO_0000531"},{"id":"T24","span":{"begin":19,"end":24},"obj":"http://purl.obolibrary.org/obo/CL_0000000"},{"id":"T25","span":{"begin":241,"end":245},"obj":"http://purl.obolibrary.org/obo/IDO_0000531"}],"text":"nd entry into host cells along with their location on the viral surface, Spike proteins are often used as immunogens for vaccines to generate neutralizing antibodies and frequently targeted for inhibition by small molecules that might block host receptor binding and/or membrane fusion (Li, 2016; Watanabe et al., 2019). In similar fashion, wild-type or catalytically"}
LitCovid-sample-PD-FMA
{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T19","span":{"begin":19,"end":24},"obj":"Body_part"},{"id":"T20","span":{"begin":79,"end":87},"obj":"Body_part"}],"attributes":[{"id":"A19","pred":"fma_id","subj":"T19","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A20","pred":"fma_id","subj":"T20","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"nd entry into host cells along with their location on the viral surface, Spike proteins are often used as immunogens for vaccines to generate neutralizing antibodies and frequently targeted for inhibition by small molecules that might block host receptor binding and/or membrane fusion (Li, 2016; Watanabe et al., 2019). In similar fashion, wild-type or catalytically"}
LitCovid-sample-PD-GO-BP-0
{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T9","span":{"begin":3,"end":24},"obj":"http://purl.obolibrary.org/obo/GO_0030260"},{"id":"T10","span":{"begin":3,"end":18},"obj":"http://purl.obolibrary.org/obo/GO_0044409"},{"id":"T11","span":{"begin":270,"end":285},"obj":"http://purl.obolibrary.org/obo/GO_0061025"}],"text":"nd entry into host cells along with their location on the viral surface, Spike proteins are often used as immunogens for vaccines to generate neutralizing antibodies and frequently targeted for inhibition by small molecules that might block host receptor binding and/or membrane fusion (Li, 2016; Watanabe et al., 2019). In similar fashion, wild-type or catalytically"}
LitCovid-sample-GO-BP
{"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T9","span":{"begin":3,"end":18},"obj":"http://purl.obolibrary.org/obo/GO_0044409"},{"id":"T10","span":{"begin":270,"end":285},"obj":"http://purl.obolibrary.org/obo/GO_0061025"}],"text":"nd entry into host cells along with their location on the viral surface, Spike proteins are often used as immunogens for vaccines to generate neutralizing antibodies and frequently targeted for inhibition by small molecules that might block host receptor binding and/or membrane fusion (Li, 2016; Watanabe et al., 2019). In similar fashion, wild-type or catalytically"}
2_test
{"project":"2_test","denotations":[{"id":"32841605-27578435-19659469","span":{"begin":291,"end":295},"obj":"27578435"},{"id":"32841605-31121217-19659470","span":{"begin":314,"end":318},"obj":"31121217"}],"text":"nd entry into host cells along with their location on the viral surface, Spike proteins are often used as immunogens for vaccines to generate neutralizing antibodies and frequently targeted for inhibition by small molecules that might block host receptor binding and/or membrane fusion (Li, 2016; Watanabe et al., 2019). In similar fashion, wild-type or catalytically"}